Literature DB >> 27118522

Pulmonary Resection for Metastatic Gastric Cancer.

Yoshihito Iijima1, Hirohiko Akiyama, Maiko Atari, Mitsuro Fukuhara, Yuki Nakajima, Hiroyasu Kinosita, Hidetaka Uramoto.   

Abstract

BACKGROUND: Pulmonary metastasectomy has come to be recognized as an effective treatment for selected patients with some malignancies. On the other hand, the role of pulmonary metastasectomy for gastric cancer is still unknown. Metastasectomy is rarely indicated in cases of pulmonary metastasis from gastric cancer, because in most cases, the metastasis occurs in the form of lymphangitic carcinomatosis and the lesions are numerous. The purpose of this study was to determine the surgical outcomes and prognostic factors for survival after pulmonary metastasectomy.
METHODS: From 1985 to 2012, 10 patients underwent pulmonary metastasectomy for gastric cancer at Saitama Cancer Center, Japan. The overall survival rate was examined by the Kaplan-Meier method and univariate analysis was carried out to identify prognostic factors.
RESULTS: The overall 3-year survival rate was 30.0 %. The median follow-up period was 26.8 months (range, 6.5-96.6) after the pulmonary metastasectomy. Univariate analysis revealed an advanced pathological stage of the gastric cancer and occurrence of extrapulmonary metastasis before the pulmonary metastasectomy as unfavorable prognostic factors.
CONCLUSION: Pulmonary metastasectomy should be considered in selected patients with lung metastasis from gastric cancer. An advanced pathological stage of gastric cancer and occurrence of extrapulmonary metastasis before the pulmonary metastasectomy are unfavorable prognostic factors.

Entities:  

Mesh:

Year:  2016        PMID: 27118522      PMCID: PMC5045850          DOI: 10.5761/atcs.oa.16-00049

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  20 in total

1.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Authors:  U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  1997-01       Impact factor: 5.209

3.  Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome.

Authors:  Jee Hyun Kong; Jeeyun Lee; Chin-A Yi; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Keon Woo Park; Won Ki Kang
Journal:  Gastric Cancer       Date:  2011-10-29       Impact factor: 7.370

4.  Pulmonary resection for metastatic gastric cancer.

Authors:  Clinton D Kemp; Mio Kitano; Sid Kerkar; R Taylor Ripley; Jens U Marquardt; David S Schrump; Itzhak Avital
Journal:  J Thorac Oncol       Date:  2010-11       Impact factor: 15.609

5.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Authors:  Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

6.  A case of long-term survival after surgical resection of solitary pulmonary metastasis from gastric cancer.

Authors:  Chiharu Tanai; Tetsuya Hamaguchi; Shun-ichi Watanabe; Hitoshi Katai; Naobumi Tochigi; Yasuhiro Shimada
Journal:  Jpn J Clin Oncol       Date:  2009-09-20       Impact factor: 3.019

7.  Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor.

Authors:  Been-Ren Lin; Tung-Chen Chang; Yung-Chie Lee; Po-Huang Lee; King-Jen Chang; Jin-Tung Liang
Journal:  Ann Surg Oncol       Date:  2009-01-29       Impact factor: 5.344

Review 8.  CT of pulmonary metastases with pathological correlation.

Authors:  K Hirakata; H Nakata; T Nakagawa
Journal:  Semin Ultrasound CT MR       Date:  1995-10       Impact factor: 1.875

9.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

10.  Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer.

Authors:  Meiqin Yuan; Yunshan Yang; Wangxia Lv; Zhengbo Song; Haijun Zhong
Journal:  Oncol Lett       Date:  2014-05-09       Impact factor: 2.967

View more
  9 in total

Review 1.  [Therapeutic approach in oligometastatic gastric and esophageal cancer].

Authors:  T Schmidt; S P Mönig
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

2.  Blocking CD47 Shows Superior Anti-tumor Therapeutic Effects of Bevacizumab in Gastric Cancer.

Authors:  Chenyang Shi; Jiaxin Li; Guorong Fan; Yu Liu
Journal:  Front Pharmacol       Date:  2022-05-25       Impact factor: 5.988

Review 3.  [Oligometastases in gastric and esophageal cancer : Current clinical trials and surgical concepts].

Authors:  S Beckert; A Königsrainer
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

4.  Long-term survival after pulmonary resections for multiple metastases from gastric cancer: A case report.

Authors:  Hideaki Kojima; Mitsuhiro Isaka; Shoji Takahashi; Nozomu Machida; Kazuhito Funai; Yasuhisa Ohde
Journal:  Int J Surg Case Rep       Date:  2018-03-21

5.  The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matching and coarsened exact matching.

Authors:  Lu-Ping Yang; Zi-Xian Wang; Ming-Ming He; Ying Jin; Chao Ren; Zhi-Qiang Wang; Feng-Hua Wang; Yu-Hong Li; Feng Wang; Rui-Hua Xu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

Review 6.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

7.  An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer.

Authors:  Riccardo Giampieri; Luca Cantini; Michela Del Prete; Alessandro Bittoni; Enrica Giglio; Alessandra Mandolesi; Elena Maccaroni; Andrea Lanese; Tania Meletani; Maria Giuditta Baleani; Renato Bisonni; Marina Scarpelli; Rossana Berardi
Journal:  Oncol Lett       Date:  2021-02-09       Impact factor: 2.967

8.  Pleural and pulmonary dissemination patterns from gastric adenocarcinoma among patients with treated primary disease in Latin America.

Authors:  Juliana Restrepo; Carlos Andrés Carvajal-Fierro; Helena Facundo; Felipe González; Ana María Ramírez; Rafael Beltran; Ricardo Buitrago; Andrés-Felipe Jimenez; José Carreño; Ricardo Oliveros
Journal:  Front Surg       Date:  2022-09-07

9.  Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.

Authors:  Yinghua Li; Danna Xie; Xiaojing Chen; Teng Hu; Simin Lu; Yunwei Han
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.